These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 6334362)

  • 1. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.
    Nemeroff CB; Widerlöv E; Bissette G; Walléus H; Karlsson I; Eklund K; Kilts CD; Loosen PT; Vale W
    Science; 1984 Dec; 226(4680):1342-4. PubMed ID: 6334362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.
    Banki CM; Bissette G; Arato M; O'Connor L; Nemeroff CB
    Am J Psychiatry; 1987 Jul; 144(7):873-7. PubMed ID: 3496802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.
    Bissette G; Widerlöv E; Walléus H; Karlsson I; Eklund K; Forsman A; Nemeroff CB
    Arch Gen Psychiatry; 1986 Dec; 43(12):1148-51. PubMed ID: 3778111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia.
    Risch SC; Lewine RJ; Kalin NH; Jewart RD; Risby ED; Caudle JM; Stipetic M; Turner J; Eccard MB; Pollard WE
    Neuropsychopharmacology; 1992 Feb; 6(2):95-100. PubMed ID: 1319168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid neuropeptides in mood disorder and dementia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    J Affect Disord; 1992 May; 25(1):39-45. PubMed ID: 1352520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
    Molchan SE; Hill JL; Martinez RA; Lawlor BA; Mellow AM; Rubinow DR; Bissette G; Nemeroff CB; Sunderland T
    Psychoneuroendocrinology; 1993; 18(7):509-19. PubMed ID: 7903467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple regression analysis.
    Newport DJ; Heim C; Owens MJ; Ritchie JC; Ramsey CH; Bonsall R; Miller AH; Nemeroff CB
    Neuropsychopharmacology; 2003 Mar; 28(3):569-76. PubMed ID: 12629539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin.
    Nemeroff CB; Bissette G; Akil H; Fink M
    Br J Psychiatry; 1991 Jan; 158():59-63. PubMed ID: 1673078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I; Bissette G; Dettling M; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Nemeroff CB; Holsboer F
    Depress Anxiety; 1998; 8(2):71-9. PubMed ID: 9784981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diazepam-binding inhibitor and corticotropin-releasing hormone in cerebrospinal fluid.
    Roy A; Pickar D; Gold P; Barbaccia M; Guidotti A; Costa E; Linnoila M
    Acta Psychiatr Scand; 1989 Sep; 80(3):287-91. PubMed ID: 2816471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
    Geracioti TD; Orth DN; Ekhator NN; Blumenkopf B; Loosen PT
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1325-30. PubMed ID: 1317385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression.
    France RD; Urban B; Krishnan KR; Bissett G; Banki CM; Nemeroff C; Speilman FJ
    Biol Psychiatry; 1988 Jan; 23(1):86-8. PubMed ID: 2962646
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims.
    Nemeroff CB; Owens MJ; Bissette G; Andorn AC; Stanley M
    Arch Gen Psychiatry; 1988 Jun; 45(6):577-9. PubMed ID: 2837159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid corticotropin-releasing factor levels and stimulation test in dementia of the Alzheimer type.
    Martignoni E; Petraglia F; Costa A; Monzani A; Genazzani AR; Nappi G
    J Clin Lab Anal; 1990; 4(1):5-8. PubMed ID: 2313466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects.
    Carpenter LL; Tyrka AR; McDougle CJ; Malison RT; Owens MJ; Nemeroff CB; Price LH
    Neuropsychopharmacology; 2004 Apr; 29(4):777-84. PubMed ID: 14702025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA; Rubinow DR; Doran AR; Roy A; Davis CL; Calabrese JR; Nieman LK; Post RM; Chrousos GP; Gold PW
    Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.
    Geracioti TD; Loosen PT; Orth DN
    Biol Psychiatry; 1997 Aug; 42(3):165-74. PubMed ID: 9232208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Psychiatry Res; 1992 Jul; 43(1):13-21. PubMed ID: 1359593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic function.
    Roy A; Pickar D; Linnoila M; Chrousos GP; Gold PW
    Psychiatry Res; 1987 Mar; 20(3):229-37. PubMed ID: 3495811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.